Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Fecal microbiota transplant with prebiotic nutrition for functional constipation

Official title: The Safety and Efficacy of Fecal Microbiota Transplantation Combined With Nutritional Intervention in the Treatment of Functional Constipation:a Pilot Study

Run by Peking Union Medical College Hospital · NCT07387952 · Data updated 2026-11-12

This will try fecal microbiota transplantation combined with a prebiotic nutrition plan to see if it helps adults aged 18–70 with chronic functional constipation that hasn’t improved with diet or laxatives.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment5 (estimated)
SponsorPeking Union Medical College Hospital
Academic / other
Locations1 site (Beijing)
StatusRecruiting
StartedJuly 30, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedFebruary 4, 2026
Trial IDNCT07387952 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 18–70 with Rome IV functional constipation for at least six months who have not responded to dietary measures and at least two laxatives or probiotic treatments.

Probably not a fit

People who are pregnant or breastfeeding, who meet criteria for IBS rather than functional constipation, or who have secondary causes of constipation or contraindications to FMT are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot interventional trial at Peking Union Medical College Hospital will give adults with Rome IV functional constipation fecal microbiota transplantation (FMT) combined with a targeted prebiotic nutritional intervention using a co-localization strategy. Participants must be 18–70 years old, have symptoms for at least six months, and have failed standard dietary measures and at least two laxatives or probiotics. Investigators will monitor safety and clinical outcomes such as stool frequency and consistency, and will analyze changes in fecal microbiota composition and metabolomic profiles. Outcomes will be compared over follow-up visits to determine whether the combined intervention produces clinical improvement and acceptable safety.

Why it matters

Potential benefit: If successful, the combined FMT and prebiotic approach could increase bowel movements, improve stool consistency, and reduce reliance on laxatives without surgery.

How similar studies have gone: Prior research suggests probiotics, prebiotics, and FMT can help chronic constipation, but combining FMT with a co-localized nutritional prebiotic intervention is a novel, pilot approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age: 18 to 70.
2. Diagnostic criteria: Functional constipation (FC) in accordance with Rome IV criteria, which should meet the following conditions:

   * Symptom requirements: The following at least 2 items should occur in ≥25% of bowel movements: a. Straining during defecation; b. Hard stool (Bristol Stool Classification score 1-2); c. Feeling of incomplete evacuation; d. Rectal obstruction sensation; e. Need for finger assistance during defecation; f. Spontaneous bowel movements \<3 times per week.
   * It is rare to have loose stools without laxatives.
   * Exclusion of irritable bowel syndrome (IBS): IBS diagnosis criteria not meeting Rome IV.
   * Disease course requirements: Symptoms persist for at least 6 months and meet the above criteria within the last 3 months.
3. Traditional treatment methods (dietary intervention, at least two laxatives or probiotics) are ineffective.

Exclusion Criteria:

1. Pregnancy or lactation.
2. Unable to take the intervention product or complete the examination as required.
3. Language expression disorder or mental illness.
4. Physical examination showed severe liver and kidney dysfunction.
5. Acute gastrointestinal disease within 4 weeks.
6. Constipation caused by surgery in the past 4 weeks.
7. History or abnormal examination: cancer, severe enteritis, intestinal obstruction, inflammatory bowel disease, hypothyroidism, mental illness, stroke, heart disease, cirrhosis, renal failure, hematopoietic system diseases, organic bowel disease suggested by colonoscopy or imaging.
8. Participation in other clinical trials within 3 months prior to enrollment.
9. Other health problems are not suitable for participation in the study.

Where it's running

  • Peking Union Medical College Hospital
    Beijing, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.